# Aurinia Pharmaceuticals Inc. (AUPH) FY2026 Q2 Balance Sheet

- Company: Aurinia Pharmaceuticals Inc. (AUPH)
- Period: As of 2026-06-30
- Filing: Q2 FY2026 10-Q, filed 2026-08-06, accession number 0001600620-26-000062
- Page: https://plicit.ai/financials/auph/fy2026-q2-balance-sheet
- Chart image: https://plicit.ai/charts/auph-fy2026-q2-balance-sheet-sankey.png

## Chart details

Balance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.

- **Assets**: 792,262,000 US dollars
- **Current assets**: 541,324,000 US dollars
- **Non-current assets**: 250,938,000 US dollars
- **Liabilities**: 177,398,000 US dollars
- **Current liabilities**: 99,893,000 US dollars
- **Non-current liabilities**: 77,505,000 US dollars
- **Equity**: 614,864,000 US dollars
- **Short-term investments**: 263,291,000 US dollars
- **Cash, cash equivalents and restricted cash**: 179,832,000 US dollars
- **Inventory**: 45,151,000 US dollars
- **Accounts receivable, net**: 41,138,000 US dollars
- **Prepaid expenses and deposits**: 10,531,000 US dollars
- **Other current assets**: 1,381,000 US dollars
- **Deferred tax assets, net**: 178,935,000 US dollars
- **Finance right-of-use lease assets**: 65,152,000 US dollars
- **Intangible assets, net**: 3,378,000 US dollars
- **Property and equipment, net**: 1,862,000 US dollars
- **Operating right-of-use lease assets**: 1,518,000 US dollars
- **Other noncurrent assets**: 93,000 US dollars
- **Accrued expenses**: 64,112,000 US dollars
- **Finance lease liabilities, current portion**: 16,479,000 US dollars
- **Deferred revenue**: 10,593,000 US dollars
- **Other current liabilities**: 5,269,000 US dollars
- **Accounts payable**: 1,735,000 US dollars
- **Operating lease liabilities, current portion**: 1,705,000 US dollars
- **Finance lease liabilities, less current portion**: 43,943,000 US dollars
- **Deferred tax benefits**: 23,128,000 US dollars
- **Deferred revenue, less current portion**: 7,480,000 US dollars
- **Operating lease liabilities, less current portion**: 2,009,000 US dollars
- **Other noncurrent liabilities**: 945,000 US dollars
- **Common shares — no par value, Unlimited shares authorized, 132,907 and 132,323 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively**: 1,117,248,000 US dollars
- **Additional paid-in capital**: 76,192,000 US dollars
- **Accumulated deficit**: negative 577,599,000 US dollars
- **Accumulated other comprehensive loss**: negative 977,000 US dollars
- **Gross equity (calculated)**: 1,193,440,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

### Chart connections

- Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
- Treasury shares and other negative equity contributions reduce equity.